US election: stockmarkets don’t care who’s in the White House
The economic cycle and America's central bank have a much bigger effect on long-term stockmarket returns than whether Democrats or Republicans are in power.
“No stimulus, no problem,” say William Watts and Sunny Oh for MarketWatch.com. This week Democrats and Republicans continued to discuss another stimulus package, but the odds of any deal before the election looked increasingly remote.
Nevertheless, bulls have decided that the American consumer can probably hold on until 2021 even without further help. Retail sales rose by 1.9% in September, the fifth straight month of gains.
That news cheered the S&P 500, which continues to trade about 3% short of its early September highs. Benefits from the $2.2trn CARES act, America’s pandemic stimulus package, ebbed over the summer, but that has yet to curb the enthusiasm of American consumers. That is because many households have a financial cushion, says Nathaniel Meyersohn for CNN Business. The US personal savings rate hit the highest level since 1981 in March.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Stockmarkets appear to be positioning for a “blue wave” that will bring Democrats to power in the presidency and Congress, paving the way for more generous stimulus measures in January next year. Analysts say that a Democratic sweep would mean more regulation for energy, financial and healthcare businesses, while extra stimulus will boost construction and renewable energy shares, says Michael Mackenzie in the Financial Times. US presidential elections always create “anxiety and volatility” in markets, but long-term investors should “ignore the short-term market noise”.
The economic cycle and the Federal Reserve have a much bigger impact on long-term returns than whether Democrats or Republicans are in power. The S&P 500 is up by 53% since Trump took office. Under Obama it bounced by 71% and it rose even more under Reagan.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Premium Bonds quiz: How much do you know about the NS&I savings product?Quiz Many savers choose Premium Bonds in the hopes of winning a prize in the monthly draws. How much do you know about the savings product?
-
UK dividends rose in final quarter of 2025, but share buybacks ate into investor payoutsLast year saw dividend growth continue to fall below pre-pandemic averages, against a backdrop of increasing share buybacks.
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust